ArQule, Inc. to Present at BIO Investor Forum Conference on October 11, 2007.Live web cast scheduled for 2:30 p.m. eastern time WOBURN, Mass. -- ArQule, Inc. (Nasdaq: ARQL) today announced that it will present at the BIO InvestorForum 2007 on Thursday, October 11, 2007 at 11:30 a.m. Pacific time (2:30 p.m. Eastern time). ArQule's presentation will be web cast live and can be accessed through the investor relations Investor relations The process by which the corporation communicates with its investors. section of the Company's website, www.arqule.com. The conference will be held at The Palace Hotel, San Francisco The current ("New") Palace Hotel (opened in 1909) is an historic hotel located in San Francisco, California, at the SW corner of Market Street and New Montgomery Street, immediately adjacent to BART's Montgomery Street Station. , California. About ArQule ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy([R]) (ACT). The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis angiogenesis /an·gio·gen·e·sis/ (-jen´e-sis) vasculogenesis; development of blood vessels either in the embryo or in the form of neovascularization or revascularization. an·gi·o·gen·e·sis n. and metastasis metastasis /me·tas·ta·sis/ (me-tas´tah-sis) pl. metas´tases 1. transfer of disease from one organ or part of the body to another not directly connected with it, due either to transfer of pathogenic microorganisms or to . The ACT platform is designed to kill cancer cells cells once believed to be peculiar to cancers, but now know to be epithelial cells differing in no respect from those found elsewhere in the body, and distinguished only by peculiarity of location and grouping. See also: Cancer selectively while sparing normal cells through direct activation of DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Hoffman-La Roche. For more information, please visit www.arqule.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion